|
| Exchange Disseminated Time | Panacea Biotec Ltd has informed BSE regarding "Panacea Biotec announces strategic alliance with Kremers Urban for 11 High Barrier to Entry Generics; and the launch of Tacrolimus Capsules in US".
Press Release:
"Panacea Biotec, India's highly progressive research based health management Company has entered into a strategic alliance with Kremers Urban Inc. (part of UCB Group) for 11 high barrier to entry generics, whose market size in US at the innovator level is around USD 4 billion." (For more details kindly refer Corporate Announcements on www.bseindia.com).
|
|
|